According to AlphaMoat, in October 2026 METiS Therapeutics (metistx.com) received 1,637 monthly visits (-58.3% MoM) — ranked #15,602 of 17,609 AI websites with traffic data, and #2,680 of 3,112 in Industry Services; its largest market is United States (89.7% of visits).
METiS Therapeutics uses artificial intelligence, machine learning, and molecular dynamics to develop delivery systems for small-molecule, biologic, and advanced nucleic-acid therapies, and combines AI with high-throughput in vivo screening to discover novel lipid nanoparticles.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 2.8K | — |
| 2026-07 | 3.1K | +10.6% |
| 2026-08 | 3.5K | +13.1% |
| 2026-09 | 3.9K | +11.9% |
| 2026-10 | 1.6K | -58.3% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, METiS Therapeutics (metistx.com) received 1,637 visits (about 1.6K) in October 2026 (-58.3% month over month), ranking #15,602 of 17,609 AI websites with traffic data, and #2680 in Industry Services.
In October 2026, METiS Therapeutics’s largest markets by share of visits are United States 89.7%, India 10.3%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.